Browsing by Subject "head and neck cancer"
Now showing items 1-5 of 5
-
Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
(Int J Cancer, 2015-11-15)Single nucleotide polymorphisms (SNPs) in the promoter region of FAS and FASLG may alter their transcriptional activity. Thus, we determined the associations between four FAS and FASLG promoter variants (FAS1377G>A, rs2234767; ... -
Dosimetric and radiobiological fitting of xerostomia and dysphagia 12 months after treatment for head and neck tumors
(2018)Oropharyngeal Squamous Cell Carcinoma (OPSCC) is by far the most predominant form of head and neck cancer in the United States. The survival rate for OPSCC is very high, which, while fortunate, yields many patients who are ... -
Improved Pre-clinical Radiation Treatment Techniques for a Novel Mouse Model of Head-and-neck Cancer
(2019)Mice are the predominant animal model used in radiation therapy research for investigating radiobiological kinetics and evaluating new therapeutics to achieve a higher therapeutic ratio in the clinic. A novel carcinogen-induced ... -
The Effects of PET Reconstruction Parameters on Radiotherapy Response Assessment and an Investigation of SUV-peak Sampling Parameters
(2013)<bold>Purpose:</bold> Our primary goal was to examine the effect of PET image reconstruction parameters on baseline and early-treatment FDG-PET/CT quantitative imaging. Early-treatment changes in tumor metabolism in primary ... -
Toward Developing Pharmacokinetic Response Criteria to Chemoradiation in Head and Neck Cancer Patients Using Dynamic Contrast-Enhanced MRI
(2012)<bold>Purpose:</bold> The purpose of this study was to assess the feasibility of using dynamic contrast-enhanced MRI to monitor early treatment-induced changes in pharmacokinetic (PK) parameters in head and neck cancer patients. ...
